MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

NxStage Medical Company Profile (NASDAQ:NXTM)

Consensus Ratings for NxStage Medical (NASDAQ:NXTM) (?)
Ratings Breakdown: 1 Sell Rating(s), 6 Buy Rating(s)
Consensus Rating:Buy (Score: 2.71)
Consensus Price Target: $24.50 (18.36% upside)

Analysts' Ratings History for NxStage Medical (NASDAQ:NXTM)
Show:
DateFirmActionRatingPrice TargetActions
6/28/2016Northland SecuritiesUpgradeMarket Perform -> OutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/7/2016BTIG ResearchReiterated RatingBuy$27.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/3/2016Piper JaffrayReiterated RatingBuy$21.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/5/2016Wells FargoReiterated RatingSellView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/4/2016Canaccord GenuityReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/11/2015Sterne Agee CRTInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/4/2015Leerink SwannBoost Price Target$24.00 -> $30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/28/2014 forward)
Earnings History for NxStage Medical (NASDAQ:NXTM)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/4/2016        
5/4/2016Q116($0.05)($0.02)$88.40 million$89.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/10/2016Q415($0.04)($0.04)$86.83 million$89.80 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/3/2015Q315($0.08)($0.03)$82.06 million$86.50 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/6/2015Q215($0.10)($0.08)$79.89 million$80.30 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/6/2015Q115($0.11)($0.09)$77.92 million$79.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/26/2015Q414($0.10)($0.08)$75.75 million$79.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/6/2014Q3($0.13)($0.11)$71.83 million$75.30 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/7/2014Q214($0.11)($0.12)$70.52 million$74.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/8/2014Q114($0.11)($0.09)$69.44 million$72.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/27/2014Q413($0.09)($0.08)$67.66 million$69.40 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/7/2013Q313$0.22($0.08)$124.03 million$66.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/25/2013Q2 2013($0.07)($0.06)$64.66 million$65.50 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/2/2013Q1 2013($0.08)($0.08)$61.14 million$61.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/28/2013Q4 2012($0.05)($0.04)$63.54 million$65.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/8/2012Q312($0.06)($0.04)$60.90 million$61.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/8/2012($0.09)($0.09)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/8/2012($0.09)($0.09)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/29/2012($0.09)($0.08)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/3/2011($0.10)($0.10)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/3/2011($0.10)($0.10)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for NxStage Medical (NASDAQ:NXTM)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163($0.06)($0.04)($0.05)
Q2 20164($0.07)($0.04)($0.05)
Q3 20165($0.04)$0.01($0.02)
Q4 20164($0.03)$0.00($0.02)
Q1 20172($0.01)($0.01)($0.01)
Q2 20172($0.01)$0.00($0.01)
Q3 20173$0.00$0.01$0.00
Q4 20173$0.01$0.02$0.01
Q1 20181$0.05$0.05$0.05
(Data provided by Zacks Investment Research)
Dividend History for NxStage Medical (NASDAQ:NXTM)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for NxStage Medical (NASDAQ:NXTM)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
5/12/2016Joseph E Turk JrPresidentSell1,500$17.89$26,835.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/10/2016Joseph E Turk JrPresidentSell1,057$18.00$19,026.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/21/2016Joseph E Turk JrPresidentSell2,000$15.73$31,460.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/14/2016Winifred L SwanSVPSell6,260$16.40$102,664.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/5/2016Joseph E Turk JrPresidentSell2,500$15.05$37,625.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/22/2016Joseph E Turk JrPresidentSell2,000$14.34$28,680.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/14/2016Winifred L SwanSVPSell620$15.69$9,727.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/10/2016Joseph E Turk JrPresidentSell2,500$15.58$38,950.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/24/2016Barry M StraubeDirectorBuy1,500$14.20$21,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/24/2016Joseph E Turk JrPresidentSell2,992$14.12$42,247.04View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/16/2016Winifred L. SwanSVPSell2,500$14.07$35,175.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/12/2016Earl R. LewisDirectorBuy21,000$14.63$307,230.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/10/2016Joseph E. Turk, Jr.PresidentSell991$16.25$16,103.75View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/9/2016Joseph E. Turk, Jr.PresidentSell2,500$16.88$42,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/4/2016Joseph E. Turk, Jr.PresidentSell991$19.60$19,423.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/20/2016Joseph E Turk JrPresidentSell2,000$18.75$37,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/14/2016Winifred L. SwanSVPSell620$19.04$11,804.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/11/2016Matthew W. TowseSVPSell3,472$20.40$70,828.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/8/2016Joseph E. Turk, Jr.PresidentSell1,500$21.03$31,545.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/7/2016Joseph E. Turk, Jr.PresidentSell3,713$20.78$77,156.14View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/22/2015Joseph E. Turk, Jr.PresidentSell5,000$20.92$104,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/16/2015Joseph E. Turk, Jr.PresidentSell800$19.99$15,992.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/15/2015Matthew W. TowseSVPSell2,863$19.51$55,857.13View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/14/2015Winifred L. SwanSVPSell2,500$18.90$47,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/10/2015Jeffrey H. BurbankCEOSell9,274$18.94$175,649.56View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/8/2015Joseph E. Turk, Jr.PresidentSell2,913$19.38$56,453.94View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/20/2015Craig W MooreDirectorSell1,000$20.00$20,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/19/2015Joseph E Turk JrPresidentSell2,000$19.65$39,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/18/2015Craig W MooreDirectorSell4,000$19.60$78,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/16/2015Winifred L. SwanSVPSell2,500$19.65$49,125.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/12/2015Joseph E. Turk, Jr.PresidentSell4,055$20.44$82,884.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/10/2015Jeffrey H. BurbankCEOSell10,000$20.75$207,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/10/2015Joseph E. Turk, Jr.PresidentSell7,500$21.03$157,725.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/10/2015Matthew W. TowseSVPSell2,863$20.32$58,176.16View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/9/2015Daniel A GianniniDirectorSell6,593$20.30$133,837.90View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/9/2015Jeffrey H. BurbankCEOSell10,000$20.32$203,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/4/2015Joseph E. Turk, Jr.PresidentSell4,826$19.62$94,686.12View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/4/2015Matthew W. TowseSVPSell8,591$19.50$167,524.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/3/2015Robert S. BrowninsiderSell44,400$19.00$843,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/20/2015Joseph E. Turk, Jr.PresidentSell2,000$15.80$31,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/16/2015Jeffrey H. BurbankCEOSell10,000$15.59$155,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/15/2015Jeffrey H. BurbankCEOSell10,000$14.98$149,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/14/2015Winifred L. SwanSVPSell2,500$15.46$38,650.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/8/2015Joseph E. Turk, Jr.PresidentSell2,839$15.42$43,777.38View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/24/2015Joseph E Turk JrPresidentSell2,000$17.26$34,520.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/17/2015Jeffrey H. BurbankCEOSell10,000$16.18$161,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/16/2015Jeffrey H. BurbankCEOSell10,000$15.99$159,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/15/2015Craig W MooreDirectorSell1,000$16.00$16,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/14/2015Winifred L. SwanSVPSell2,500$16.01$40,025.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/9/2015Joseph E. Turk, Jr.PresidentSell2,839$16.54$46,957.06View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/25/2015Joseph E Turk JrPresidentSell2,000$18.25$36,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/17/2015Robert S BrownInsiderSell10,825$18.30$198,097.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/14/2015Winifred L SwanSVPSell2,500$18.14$45,350.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/13/2015Jeffrey H BurbankCEOSell10,000$18.31$183,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/12/2015Jeffrey H BurbankCEOSell10,000$18.03$180,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/12/2015Joseph E Turk JrPresidentSell3,252$17.74$57,690.48View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/22/2015Joseph E Turk JrPresidentSell2,000$13.86$27,720.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/14/2015Winifred L SwanSVPSell2,500$14.71$36,775.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/23/2015Joseph E Turk JrPresidentSell2,000$15.36$30,720.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/18/2015Jeffrey H BurbankCEOSell20,000$15.56$311,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/15/2015Winifred L SwanSVPSell2,500$15.48$38,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/10/2015Joseph E Turk JrPresidentSell2,839$16.00$45,424.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/18/2015Winifred L SwanSVPSell2,500$16.65$41,625.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/12/2015Jeffrey H BurbankCEOSell10,000$16.44$164,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/21/2015Joseph E Turk JrPresidentSell1,950$18.40$35,880.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/17/2015Jeffrey H BurbankCEOSell10,000$18.08$180,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/16/2015Jeffrey H BurbankCEOSell10,000$18.31$183,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/8/2015Joseph E Turk JrPresidentSell1,500$18.34$27,510.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/26/2015Joseph E Turk JrPresidentSell1,150$16.94$19,481.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/18/2015Jeffrey H BurbankCEOSell20,000$17.40$348,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/10/2015Joseph E Turk JrPresidentSell1,500$16.44$24,660.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/25/2015Joseph E Turk JrPresidentSell2,082$17.88$37,226.16View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/27/2015Joseph E Turk JrPresidentSell2,350$18.70$43,945.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/14/2015Winifred L SwanSVPSell500$18.44$9,220.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/13/2015Joseph E Turk JrPresidentSell1,500$18.35$27,525.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/13/2015Winifred L SwanSVPSell666$18.35$12,221.10View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/29/2014Winifred L SwanSVPSell667$18.17$12,119.39View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/23/2014Joseph E Turk JrPresidentSell2,350$18.44$43,334.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/15/2014Joseph E Turk JrPresidentSell2,000$17.45$34,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/15/2014Kevin HershbergerCAOSell8,000$17.19$137,520.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/10/2014Joseph E Turk JrPresidentSell1,500$17.77$26,655.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/5/2014Jeffrey H BurbankCEOSell5,000$17.16$85,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/2/2014Robert S BrownInsiderSell34,700$17.44$605,168.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/1/2014Joseph E Turk JrPresidentSell24,762$17.04$421,944.48View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/1/2014Winifred L SwanSVPSell16,667$17.04$284,005.68View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/25/2014Joseph E Turk JrPresidentSell3,350$17.59$58,926.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/14/2014Joseph E Turk JrPresidentSell29,560$17.39$514,048.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/14/2014Winifred L SwanSVPSell17,167$17.37$298,190.79View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/12/2014Joseph E Turk JrPresidentSell26,261$16.27$427,266.47View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/12/2014Kevin HershbergerCAOSell11,056$16.58$183,308.48View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/7/2014Joseph E Turk JrPresidentSell24,761$16.25$402,366.25View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/3/2014Joseph E Turk JrPresidentSell5,717$15.50$88,613.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/23/2014Joseph E Turk JrPresidentSell3,550$14.55$51,652.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/23/2014Robert S BrownInsiderSell45,370$14.53$659,226.10View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/24/2014Joseph E Turk JrPresidentSell3,550$13.34$47,357.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/19/2014Jeffrey H BurbankCEOSell2,416$14.00$33,824.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/19/2014Joseph E Turk JrPresidentSell1,500$14.00$21,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/10/2014Kevin HershbergerCAOSell843$13.58$11,447.94View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/8/2014Jeffrey H BurbankCEOSell2,322$14.00$32,508.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/8/2014Joseph E Turk JrPresidentSell1,500$14.00$21,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/27/2014Joseph E Turk JrPresidentSell2,550$13.06$33,303.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/15/2014Winifred L SwanSVPSell2,500$13.60$34,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/7/2014Jeffrey H BurbankCEOSell5,000$14.00$70,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/7/2014Joseph E Turk JrPresidentSell1,500$14.00$21,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/24/2014Joseph E Turk JrPresidentSell3,550$13.50$47,925.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/18/2014Winifred L SwanSVPSell2,000$13.46$26,920.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/24/2014Joseph E Turk JrPresidentSell3,950$14.43$56,998.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/20/2014Jeffrey H BurbankCEOSell5,000$14.00$70,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/17/2014Joseph E Turk JrPresidentSell1,500$14.00$21,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/9/2014Winifred L SwanSVPSell9,228$14.00$129,192.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/5/2014Jeffrey H BurbankCEOSell5,000$14.00$70,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/5/2014Joseph E Turk JrPresidentSell1,500$14.00$21,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/5/2014Winifred L SwanSVPSell7,500$14.00$105,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/29/2014Joseph E Turk JrPresidentSell4,035$13.60$54,876.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/15/2014Winifred SwanSVPSell9,629$12.80$123,251.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/14/2014Winifred SwanSVPSell5,000$13.04$65,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/6/2014Robert FunariDirectorBuy10,150$14.72$149,408.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/21/2013Robert S BrownInsiderSell140,100$14.00$1,961,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/9/2013Thomas SheaSVPSell1,000$12.30$12,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/12/2013Thomas SheaSVPSell1,172$12.93$15,153.96View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/8/2013Thomas SheaSVPSell7,000$14.34$100,380.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/10/2013Thomas SheaSVPSell5,000$13.73$68,650.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/13/2013Thomas SheaSVPSell15,724$12.67$199,223.08View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/13/2012David S UtterbergDirectorSell184,204$11.58$2,133,082.32View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/2/2012David S UtterbergDirectorSell34,730$11.13$386,544.90View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for NxStage Medical (NASDAQ:NXTM)
DateHeadline
06/28/16 08:26 AMNxstage Medical upgraded by Northland Capital -
06/27/16 04:01 PMNXSTAGE MEDICAL, INC. Files SEC form 8-K, Change in Directors or Principal Officers -
06/23/16 06:05 PMWhy Investors Love These Medical Appliances & Equipment's Stocks? - Align Technology, ZELTIQ Aesthetics, Amedica, and Nxstage Medical
06/22/16 06:57 AMNextcom Ltd. (Israel) :NXTM-IL: Earnings Analysis: Q1, 2016 By the Numbers : June 22, 2016 -
06/13/16 04:26 PMNXSTAGE MEDICAL, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement -
06/11/16 08:27 AMNxStage Medical Stock Sees Short Interest Expand By 10.6%
06/09/16 07:40 AMNxstage Medical (NXTM) Catches Eye: Stock Jumps 5.6% -
06/02/16 02:28 PMNextcom Ltd. (Israel) :NXTM-IL: Earnings Analysis: 2015 By the Numbers : June 2, 2016 -
06/01/16 03:31 PMNXSTAGE MEDICAL, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -
05/27/16 12:10 AMEarnings Review and Stock Rundown for NxStage Medical, Inc. (NASDAQ:NXTM) - Wall Street Hints and News - Earnings Review and Stock Rundown for NxStage Medical, Inc. (NASDAQ:NXTM)Wall Street Hints and NewsInvestors and analysts will be paying close attention when the company posts earnings results. Earnings numbers can provide insight into a company's overall profitability. Covering equity analysts are expecting NxStage Medical, Inc. (NASDAQ:NXTM) to ...and more »
05/24/16 07:06 AMNxStage Announces Second Quarter 2016 Investor Conference Schedule - [at noodls] - LAWRENCE, Mass., May 24, 2016 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, today announced that Jeffrey H. Burbank, Chief ...
05/23/16 06:50 PMIt's Earnings Time: What to Do with Nxstage Medical, Inc. (NASDAQ:NXTM) Stock - iStreetWire - It's Earnings Time: What to Do with Nxstage Medical, Inc. (NASDAQ:NXTM) StockiStreetWireNxstage Medical, Inc. (NXTM) added 1.98% to reach at the floor price of $18.01 as the company is set to share its next quarterly earnings on August 03, 2016. NXTM stock trades between $16.42 and $18.25 before the earnings release. Let's take a closer ...Cortina Asset Management buys $36.5 Million stake in NxStage Medical (NXTM)Market Digestall 2 news articles »
05/17/16 11:01 AMNxStage Medical (NXTM): Bear Thesis Has No Teeth - Piper Jaffray - StreetInsider.com - NxStage Medical (NXTM): Bear Thesis Has No Teeth - Piper JaffrayStreetInsider.com... evaluates the bear thesis on NxStage Medical (NASDAQ: NXTM) and recommends investors use pullbacks as buying opportunities. No change to Overweight rating or $21 PT. The bear argument focuses on two points: 1) the company's HHD performance ...and more »
05/16/16 06:33 PMNxstage Medical Incorporated (NASDAQ:NXTM) Shorted Shares Increased By 6.32% - Wall Street Hints and News - Nxstage Medical Incorporated (NASDAQ:NXTM) Shorted Shares Increased By 6.32%Wall Street Hints and NewsThe short interest to Nxstage Medical Incorporated's float is 8.74%. The stock increased 1.28% or $0.23 during the last trading session, hitting $18.15. About 408,053 shares traded hands. NxStage Medical, Inc. (NASDAQ:NXTM) has risen 13.78% since ...NxStage Medical (NXTM): Bear Thesis Has No Teeth - Piper JaffrayStreetInsider.comall 2 news articles »
05/16/16 12:12 PMTwo Movers within Investors Observation: EPIRUS Biopharmaceuticals, Inc. (NASDAQ:EPRS) , NxStage Medical, Inc ... - Street Updates - Two Movers within Investors Observation: EPIRUS Biopharmaceuticals, Inc. (NASDAQ:EPRS) , NxStage Medical, Inc ...Street UpdatesNxStage Medical, Inc. (NASDAQ:NXTM) moved in red zone with decline of -0.07 points or -0.39% to $17.92. The company has a market worth of $1.15B.Total 520.19 thousand shares were exchanged in last trading session as opposed to average volume of ...and more »
05/11/16 07:17 PMNxStage Medical, Inc. (NXTM) President Joseph E. Turk, Jr. Sells 1057 Shares - Washington News Wire - Washington News WireNxStage Medical, Inc. (NXTM) President Joseph E. Turk, Jr. Sells 1057 SharesWashington News WireNxStage Medical logo NxStage Medical, Inc. (NASDAQ:NXTM) President Joseph E. Turk, Jr. sold 1,057 shares of the stock in a transaction on Tuesday, May 10th. The shares were sold at an average price of $18.00, for a total transaction of $19,026.00.NxStage Medical, Inc. (NASDAQ:NXTM) Comprehensive Income At $-4.031 For Period Ended 2015-12-31Vanguard TribuneNxStage Medical, Inc. (NASDAQ:NXTM) Basic Consolidated EPS At $-0.2565Investor NewswireNxStage Medical Inc. (NXTM) is Trading Higher on Unusual Volume for May 09Equities.comRisers & Fallers -The Postall 9 news articles »
05/11/16 07:17 PMNxStage Medical, Inc. (NASDAQ:NXTM) Is Trading Down – Insider Trading Activity - There has been some selling insider activity on NxStage Medical, Inc. recently. Yesterday President Joseph E. Jr Turk disclosed the sale of 2,000 shares of NXTM stock. The shares were sold on April 21st for an average price of $15.73. Turk now owns $ ...
05/09/16 06:59 PMNxStage Medical Inc. (NXTM) Jumps 6.49% on May 09 - Equities.com - NxStage Medical Inc. (NXTM) Jumps 6.49% on May 09Equities.comNxStage Medical Inc. (NXTM) was among the biggest gainers on the Russell 2000 for Monday May 09 as the stock popped 6.49% to $17.89, representing a gain of $1.09 per share. Some 1.05 million shares traded hands on 7,768 trades, compared with an ...and more »
05/05/16 07:47 PMEarnings Outlook on NxStage Medical, Inc. (NASDAQ:NXTM) - B.O.D.Y Confidential - Earnings Outlook on NxStage Medical, Inc. (NASDAQ:NXTM)B.O.D.Y ConfidentialAnalysts and investors will be anticipating NxStage Medical, Inc. (NASDAQ:NXTM)'s next earnings release which is expected to be posted on or around 2016-08-04. Sell-side research firms on Wall Street are expecting that the company will post EPS of ...and more »
05/05/16 11:32 AMNxStage Medical, Inc. :NXTM-US: Earnings Analysis: Q1, 2016 By the Numbers -
05/04/16 03:51 PMEdited Transcript of NXTM earnings conference call or presentation 4-May-16 1:00pm GMT -
05/04/16 11:28 AMNxStage Medical Cuts Its Losses as Critical Care Leads Sales Higher - The dialysis services company managed to limit its red ink more effectively than investors had expected.
05/04/16 08:00 AMNxStage Medical Inc Earnings Call scheduled for 9:00 am ET today -
05/04/16 07:25 AMNXSTAGE MEDICAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exh -
05/04/16 07:20 AMNxStage reports 1Q loss -
05/04/16 07:13 AM8:13 am Nxstage Medical beats by $0.03, slight beat on revs; guides Q2 revs above consensus; guides to higher end of prior FY16 revenue guidance -
05/04/16 07:10 AMNxStage Reports First Quarter Financial Results - [at noodls] - LAWRENCE, Mass., May 4, 2016 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, today reported first quarter financial results above ...
05/04/16 06:07 AMQ1 2016 NxStage Medical Inc Earnings Release - Before Market Open -
05/03/16 07:06 PMAverage Analyst Rating for NxStage Medical, Inc. (NASDAQ:NXTM) - B.O.D.Y Confidential - Average Analyst Rating for NxStage Medical, Inc. (NASDAQ:NXTM)B.O.D.Y ConfidentialWall Street analysts have provided an average broker recommendation of 2 on NxStage Medical, Inc. (NASDAQ:NXTM) shares. The rating is determined by using the average of all analyst recommendations taken into consideration by Zacks Research.and more »
05/02/16 08:24 PMInvestors Attention Alert: NxStage Medical, Inc. (NASDAQ:NXTM) , Vical Incorporated (NASDAQ:VICL) - Street Updates - Web Breaking NewsInvestors Attention Alert: NxStage Medical, Inc. (NASDAQ:NXTM) , Vical Incorporated (NASDAQ:VICL)Street UpdatesOn4/29/2016, shares of NxStage Medical, Inc. (NASDAQ:NXTM) fell -2.83% in trading session and finally closed at $16.12. The company most recent volume stood at 1.11 million shares as compared to its average volume of 522.39 thousand shares. Over the ...NxStage Medical, Inc. (NXTM) to Release Quarterly Earnings on WednesdayWeb Breaking NewsNxstage Medical Incorporated (NASDAQ:NXTM) Sellers Covered 1.48% of Their ShortsB.O.D.Y Confidentialall 3 news articles »
04/29/16 07:16 PMShare Performance and Target Price Review NxStage Medical, Inc. (NASDAQ:NXTM) - B.O.D.Y Confidential - Share Performance and Target Price Review NxStage Medical, Inc. (NASDAQ:NXTM)B.O.D.Y ConfidentialDuring the most recent trading session, shares of NxStage Medical, Inc. (NASDAQ:NXTM) ended up with a move of -2.83%. Sell-side analysts have given a consensus target price of $22.79 on company shares. Target price projections may differ greatly from ...and more »
04/29/16 01:43 AMNxStage Medical, Inc. (NASDAQ:NXTM) Yearly EPS Estimate At $-0.03 - RealistInvestor.com - NxStage Medical, Inc. (NASDAQ:NXTM) Yearly EPS Estimate At $-0.03RealistInvestor.comAs of 2017-03-31, Zacks is projecting average per-share earnings of $-0.03 for NxStage Medical, Inc. (NASDAQ:NXTM) for the year ended 2017. The projected median EPS is $-0.025, which is based on 4 analysts calls. It is based on the research reports of ...
04/25/16 07:09 AMNxStage to Present at the Deutsche Bank 41st Annual Health Care Conference - [at noodls] - LAWRENCE, Mass., April 25, 2016 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, today announced that Jeffrey H. Burbank, Chief ...
04/24/16 09:12 PMNxstage Medical, Inc. (NXTM) Files Form 4 Insider Selling : Joseph E Jr Turk Sells 2000 Shares - Market Digest - Mas Market NewsNxstage Medical, Inc. (NXTM) Files Form 4 Insider Selling : Joseph E Jr Turk Sells 2000 SharesMarket DigestNxstage Medical, Inc. (NXTM): Joseph E Jr Turk , President of Nxstage Medical, Inc. sold 2,000 shares on Apr 21, 2016. The Insider selling transaction was reported by the company on Apr 22, 2016 to the Securities and Exchange Commission. The shares ...NxStage Medical, Inc. (NXTM) President Joseph E. Turk, Jr. Sells 2000 SharesMas Market NewsNxStage Medical, Inc. (NASDAQ:NXTM) Updated Analyst CoverageRisers & FallersNxStage Medical, Inc. (NASDAQ:NXTM)'s Insider Joseph Turk Sold 2000 SharesB.O.D.Y Confidentialall 5 news articles »
04/23/16 01:25 AMBroker Roundup For NxStage Medical, Inc. (NASDAQ:NXTM) - Share Trading News - Broker Roundup For NxStage Medical, Inc. (NASDAQ:NXTM)Share Trading News02/28/2014 – NxStage Medical, Inc. had its “buy” rating reiterated by analysts at Jefferies. They now have a USD 17 price target on the stock. The share price of NxStage Medical, Inc. (NASDAQ:NXTM) was up +0.79% during the last trading session, with a ...and more »
04/21/16 08:10 PMHow The Pieces Add Up: XHE Targets $50 - Three of XHE's underlying holdings with notable upside to their analyst target prices are Accuray Inc (ARAY), NxStage Medical Inc (NXTM), and Wright Medical Group NV (WMGI). Although ARAY has traded at a recent price of $6.18/share, the average analyst ...
04/18/16 04:33 PMNxStage Medical, Inc. – Value Analysis (NASDAQ:NXTM) : April 18, 2016 -
04/18/16 04:12 PMETF’s with exposure to NxStage Medical, Inc. : April 18, 2016 -
04/15/16 07:04 AMNxStage Medical, Inc. breached its 50 day moving average in a Bullish Manner : NXTM-US : April 15, 2016 -
04/14/16 09:05 PMEarnings Watch on NxStage Medical, Inc. (NASDAQ:NXTM) - RiversideGazette.com - Earnings Watch on NxStage Medical, Inc. (NASDAQ:NXTM)RiversideGazette.comNxStage Medical, Inc. (NASDAQ:NXTM) has a consensus earnings per share estimate for the current quarter of $-0.05 based on compiled analyst projections. The company is next expected to release earnings on or around 2016-05-04 for the period ending ...and more »
04/13/16 07:27 PMNxStage Medical, Inc. (NASDAQ:NXTM): Quick Look at Earnings - News Tribune - NxStage Medical, Inc. (NASDAQ:NXTM): Quick Look at EarningsNews TribuneWhen NxStage Medical, Inc. (NASDAQ:NXTM) issues their next quarterly report on or near 2016-05-04, Wall Street analysts are predicting they will report earnings per share of $-0.05. This consensus EPS number is provided by Zacks Research, which might ...and more »
04/13/16 07:27 PMNxstage Medical Incorporated (NASDAQ:NXTM) Shorted Shares Increased 4.95% After Market Selling - RiversideGazette.com - Nxstage Medical Incorporated (NASDAQ:NXTM) Shorted Shares Increased 4.95% After Market SellingRiversideGazette.comThe short interest to Nxstage Medical Incorporated's float is 7.92%. The stock increased 1.49% or $0.22 during the last trading session, hitting $14.98. About 388,660 shares traded hands. NxStage Medical, Inc. (NASDAQ:NXTM) has declined 10.87% since ...
04/12/16 07:25 AMNxStage Kidney Care Opens New Dialysis Centers in Baltimore, Maryland - [at noodls] - LAWRENCE, Mass., April 12, 2016 /PRNewswire/ -- NxStage Kidney Care, Inc., a subsidiary of NxStage Medical, Inc., today announced the opening of two new dialysis centers in Baltimore, Maryland. The centers, ...
04/12/16 12:48 AMNxStage Medical, Inc. (NASDAQ:NXTM): Quarterly EPS Estimate Of $-0.06 - Investor Newswire - NxStage Medical, Inc. (NASDAQ:NXTM): Quarterly EPS Estimate Of $-0.06Investor NewswireThe EPS estimates reported seven and 30 days ago were $-0.06 and $-0.06 respectively. While the EPS estimates reported 60 and 90 days ago were $-0.06 and $-0.06 respectively. The percentage change in EPS_MEAN_EST from 7 days ago is 0.03%.and more »
04/12/16 12:48 AMNxStage Medical, Inc. (NASDAQ:NXTM) Analyst Recommendation Outlook - Clinton Financial - NxStage Medical, Inc. (NASDAQ:NXTM) Analyst Recommendation OutlookClinton FinancialCovering analysts usually give Buy, Sell and Hold recommendations along with guidance and company earnings estimates. There are 5 analysts providing ratings for NxStage Medical, Inc. (NASDAQ:NXTM). 4 have given the stock a “Strong Buy”, 0 rate it a ...and more »
04/11/16 07:20 AMNxStage® to Report First Quarter 2016 Financial Results - [at noodls] - LAWRENCE, Mass., April 11, 2016 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, today announced plans to release its financial ...
04/07/16 09:37 PMNxstage Medical Inc (NASDAQ:NXTM) Institutional Investors Sentiment - RiversideGazette.com - Nxstage Medical Inc (NASDAQ:NXTM) Institutional Investors SentimentRiversideGazette.comNxstage Medical Inc (NASDAQ:NXTM) institutional sentiment increased to 1.07 in 2015 Q3. Its up 0.07, from 1 in 2015Q2. The ratio is more positive, as 66 funds increased and opened new holdings, while 66 reduced and sold positions in Nxstage Medical Inc.
04/07/16 07:00 AMNational Donate Life Month: NxStage Teams Up with Organ Donation Nonprofit MatchingDonors.com - [PR Newswire] - LAWRENCE, Mass., April 7, 2016 /PRNewswire/ -- Thirteen people die every day in the United States waiting for a kidney transplant, most waiting seven to nine years, according to the U.S. Department of Health and Human Services. April is National Donate Life Month and NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, is joining forces with MatchingDonors.com, the nation's largest nonprofit living organ donation website that provides people with an active way to search for an altruistic live donor. The organizations are teaming up to raise awareness of treatment options and services that may help kidney patients receive a transplant.
04/06/16 08:38 PMKopp Investment Advisors buys $2.5 Million stake in NxStage Medical (NXTM) - Everything HUDSON - Kopp Investment Advisors buys $2.5 Million stake in NxStage Medical (NXTM)Everything HUDSONNxStage Medical makes up approx 0.01% of Blackrock Fund Advisors's portfolio.Broadview Advisors reduced its stake in NXTM by selling 262,570 shares or 24.5% during the fourth quarter. The Hedge Fund company now holds 809,180 shares of NXTM ...
04/05/16 07:38 PMAnalyst Ratings Check NxStage Medical, Inc. (NASDAQ:NXTM) - Business Standard Tribune - Analyst Ratings Check NxStage Medical, Inc. (NASDAQ:NXTM)Business Standard TribuneCovering sell-side analysts have an average rating of 1.86 on shares of NxStage Medical, Inc. (NASDAQ:NXTM). This Zacks Research number is compiled from analysts that they have taken into consideration. This consensus rating lands on a 1 to 5 scale.and more »
About NxStage Medical

NxStage Medical logoNxStage Medical, Inc. is a medical device company. The Company is engaged in the development, manufacturing and marketing of products for the treatment of kidney failure, fluid overload and related blood treatments and procedures. The Company's products include the System One, Streamline Blood Tubing Sets and AV Fistula and Apheresis Needles. Its primary product, the System One, is a small, portable, easy-to-use hemodialysis system. It is designed to deliver the therapeutic flexibility and clinical benefits associated with traditional dialysis machines in a smaller, portable, easy-to-use form that can be used by healthcare professionals and trained lay users alike in a variety of settings, including patient homes, as well as more traditional care settings such as hospitals and dialysis centers. The Company operates in three reportable business segments: System One, In-Center and Services.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: Health Care Equipment
  • Exchange: NASDAQ
  • Symbol: NXTM
  • CUSIP: 67072V10
Key Metrics:
  • Previous Close: $20.70
  • 50 Day Moving Average: $19.18
  • 200 Day Moving Average: $17.59
  • P/E Ratio: N/A
  • P/E Growth: -8.11
  • Market Cap: $1.33B
  • Current Quarter EPS Consensus Estimate: $-0.12 EPS
Additional Links:
NxStage Medical (NASDAQ:NXTM) Chart for Tuesday, June, 28, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha